In the past week, OCGN stock has gone down by -22.81%, with a monthly gain of 6.45% and a quarterly surge of 157.81%. The volatility ratio for the week is 12.39%, and the volatility levels for the last 30 days are 14.91% for Ocugen Inc The simple moving average for the past 20 days is -18.66% for OCGN’s stock, with a 104.00% simple moving average for the past 200 days.
Is It Worth Investing in Ocugen Inc (NASDAQ: OCGN) Right Now?
Additionally, the 36-month beta value for OCGN is 3.51. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for OCGN is 251.67M and currently, short sellers hold a 17.28% ratio of that float. The average trading volume of OCGN on April 22, 2024 was 8.87M shares.
OCGN) stock’s latest price update
Ocugen Inc (NASDAQ: OCGN) has seen a decline in its stock price by 0.00 in relation to its previous close of 1.32. However, the company has experienced a -22.81% decline in its stock price over the last five trading sessions. Seeking Alpha reported 2024-04-19 that Ocugen, Inc. expects preliminary safety/efficacy data from phase 1/2 study, using OCU-410 for the treatment of patients with GA, in 2024. Preliminary safety/efficacy data from phase 1/2 study, using OCU-401ST for the treatment of patients with Stargardt Disease, expected in 2024. OCU-400 is being advanced to treat patients with Retinitis Pigmentosa in a phase 3 study; With positive data it expects to file an NDA of OCU-400 in 2026.
Analysts’ Opinion of OCGN
Many brokerage firms have already submitted their reports for OCGN stocks, with Chardan Capital Markets repeating the rating for OCGN by listing it as a “Buy.” The predicted price for OCGN in the upcoming period, according to Chardan Capital Markets is $3.50 based on the research report published on March 01, 2023 of the previous year 2023.
Mizuho, on the other hand, stated in their research note that they expect to see OCGN reach a price target of $5. The rating they have provided for OCGN stocks is “Buy” according to the report published on August 23rd, 2022.
ROTH Capital gave a rating of “Buy” to OCGN, setting the target price at $8 in the report published on June 15th of the previous year.
OCGN Trading at 11.27% from the 50-Day Moving Average
After a stumble in the market that brought OCGN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -37.29% of loss for the given period.
Volatility was left at 14.91%, however, over the last 30 days, the volatility rate increased by 12.39%, as shares sank -1.49% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +149.06% upper at present.
During the last 5 trading sessions, OCGN fell by -22.81%, which changed the moving average for the period of 200-days by +144.44% in comparison to the 20-day moving average, which settled at $1.6217. In addition, Ocugen Inc saw 129.57% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at OCGN starting from Zhang Junge, who purchase 200,278 shares at the price of $0.50 back on Jun 14 ’23. After this action, Zhang Junge now owns 1,077,182 shares of Ocugen Inc, valued at $99,999 using the latest closing price.
Stock Fundamentals for OCGN
Current profitability levels for the company are sitting at:
- -10.86 for the present operating margin
- 0.84 for the gross margin
The net margin for Ocugen Inc stands at -10.24. The total capital return value is set at -1.38. Equity return is now at value -103.61, with -74.16 for asset returns.
Based on Ocugen Inc (OCGN), the company’s capital structure generated 0.15 points at debt to capital in total, while cash flow to debt ratio is standing at -8.94. The debt to equity ratio resting at 0.17. The interest coverage ratio of the stock is 52.3.
Currently, EBITDA for the company is -64.83 million with net debt to EBITDA at 0.5. When we switch over and look at the enterprise to sales, we see a ratio of 50.89. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.51.
Conclusion
In conclusion, Ocugen Inc (OCGN) has seen better performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
